NTII Neurobiological Technologies (MM)

Neurobiological Technologies, Inc. to Present at the Wall Street Analyst Forum On December 1, 2004 Webcast Available to All Interested Investors RICHMOND, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NASDAQ:NTII) today announced that its President and Chief Executive Officer, Paul E. Freiman, will present a corporate overview at The Wall Street Analyst Forum in New York City at 11:00 a.m. on December 1, 2004. The presentation can be accessed by going to: http://www.shareholder.com/ntii/medialist.cfm . Listeners are encouraged to visit the website at least 15 minutes prior to the beginning of the scheduled presentation to register and to download and install any necessary audio software. The presentation will be available for 90 days after the event. About Neurobiological Technologies, Inc. Neurobiological Technologies, Inc. is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Paul E. Freiman, President & CEO of Neurobiological Technologies, Inc., +1-510-262-1730; or Cheryl Schneider, VP - Investor Relations, or Jeff Myhre, VP - Editorial, both of Porter, Le Vay & Rose, Inc., +1-212-564-4700, for Neurobiological Technologies, Inc. Web site: http://www.ntii.com/

Copyright